‘Miracle’ hepatitis C drugs costing £30k per patient ‘may have no clinical effect’ 

CAR-T Cancer Approach Has Surprising Success in Multiple Myeloma
June 30, 2017
Women With Aggressive Breast Cancer Are Living Longer
July 3, 2017
Show all

‘Miracle’ hepatitis C drugs costing £30k per patient ‘may have no clinical effect’ 

Clinical effect of certain hepatitis C drugs is questioned in new study.

Drugs that have been hailed as a cure for a debilitating and sometimes fatal liver disease – but have threatened to break the health budgets of most countries because of their cost – have not been proven to have any effect, according to a new review.

The startling conclusion came from the respected and independent Cochrane Collaboration, which has assessed all the drug company trials of the breakthrough hepatitis C treatments.

Hepatitis C is a viral infection that causes chronic liver disease and can lead to death from cirrhosis and cancer. Previous treatments were not very effective and had side effects that many patients could not tolerate.

Read full article: ‘Miracle’ hepatitis C drugs costing £30k per patient ‘may have no clinical effect’ | Society | The Guardian

Read Full Article: ‘Miracle’ hepatitis C drugs costing £30k per patient ‘may have no clinical effect’ | Society | The Guardian

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.